01
Why longevity forums love it
Telomerase and pineal signaling make for a powerful story. Stories are not prescriptions.
- ·Cellular-aging research interest
- ·Not an immortality peptide
- ·Not orderable
RE GEN RX · peptides / Epithalon
Under FDA review
Epithalon
A telomerase-associated peptide PCAC recommended — not approval, not orderable today.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Short cycles
What is Epithalon?
The molecule, in plain language.
Epithalon (epitalon) is a tetrapeptide associated with pineal and telomerase research. PCAC recommended it for the 503A bulks list in July 2026. RE GEN will not compound it until FDA listing and the other gates are actually done.
How people usually take it. Not orderable. No short-cycle vial from us today.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
02
The July 2026 vote
Recommended along with BPC-157, TB-500, KPV, MOTS-c, and Semax. None of them are orderable at RE GEN today.
- ·Advisory committee only
- ·Rulemaking remains
- ·We add on confirmation
03
What we can do now
Longevity visits can still cover carried mitochondrial and metabolic tools when appropriate.
- ·NAD+
- ·GLP-1 conversation if that is the real goal
- ·Consult
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
Epitalon has preclinical aging and telomerase-associated literature.
- ·Mostly non-U.S. research traditions
- ·Not a 503A listing yet
- ·Not orderable
Human research
Human evidence is limited. A PCAC recommendation is not human-use approval.
- ·Not orderable today
- ·No telomere-length promise in any case
- ·Do not buy research epitalon
Legal basis at RE GEN · July 2026
We will not compound this today.
PCAC recommended Epitalon for the 503A bulks list in July 2026. Not orderable until FDA acts. A vote is not a green light.
PCAC recommended listing is not a green light. Not orderable today.
Common questions
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is Epithalon?
A tetrapeptide in longevity research (also spelled epitalon). PCAC recommended listing in July 2026. Not orderable at RE GEN yet.
Is Epithalon FDA-approved?
Epithalon is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get Epithalon at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound Epithalon today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Will you add it after the vote?
After FDA listing and a confirmed lawful basis — not after a committee vote alone.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Related on this menu
Illinois practice · licensed 503A compounding
A committee vote is not a green light. We add a peptide when FDA does.
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.